Phosphoinositides signalling in cancer: Focus on PI3K and PLC

QR Code

Phosphoinositides signalling in cancer: Focus on PI3K and PLC

Bibliographic Details
Main Authors:	Raimondi, C., Falasca, Marco
Format:	Journal Article
Published:	2012
Online Access:	http://hdl.handle.net/20.500.11937/8041

Similar Items

Targeting phosphoinositide 3-kinase pathways in pancreatic cancer - from molecular signalling to clinical trials
by: Falasca, Marco, et al.
Published: (2011)

3-phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
by: Fyffe, C., et al.
Published: (2013)

Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)

Regulation and cellular functions of class II phosphoinositide 3-kinases
by: Falasca, Marco, et al.
Published: (2012)

Genetic and epigenetic regulation of phosphoinositide 3-kinase isoforms
by: Fyffe, C., et al.
Published: (2013)

Analysis, regulation, and roles of endosomal phosphoinositides
by: Maffucci, T., et al.
Published: (2014)

Novel roles for class II Phosphoinositide 3-Kinase C2ß in signalling pathways involved in prostate cancer cell invasion.
by: Mavrommati, I., et al.
Published: (2016)

New insight into the intracellular roles of class II phosphoinositide 3-kinases
by: Maffucci, T., et al.
Published: (2014)

Key role of phosphoinositide 3-kinase class IB in pancreatic cancer
by: Edling, C., et al.
Published: (2010)

Cudraflavone C induces tumor-specific apoptosis in colorectal cancer cells through inhibition of the phosphoinositide 3-kinase (PI3K)-AKT pathway
by: Castresana, Javier S., et al.
Published: (2017)

Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway
by: Edling, C., et al.
Published: (2014)

A phosphoinositide 3-kinase/phospholipase cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation
by: Maffucci, T., et al.
Published: (2009)

Investigating the mechanisms of activation and action of phosphoinositide 3-kinase C2 alpha in pancreatic beta cells
by: Mazza, S., et al.
Published: (2013)

Class II Phosphoinositide 3-Kinases as Novel Drug Targets
by: Falasca, Marco, et al.
Published: (2017)

Targeting PDK1 in cancer
by: Raimondi, C., et al.
Published: (2011)

Class II phosphoinositide 3-kinase C2ß regulates a novel signaling pathway involved in breast cancer progression.
by: Chikh, A., et al.
Published: (2016)

Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic ß cells
by: Dominguez, V., et al.
Published: (2011)

Class II Phosphoinositide 3-Kinases Contribute to Endothelial Cells Morphogenesis
by: Tibolla, G., et al.
Published: (2013)

PITPs as targets for selectively interfering with phosphoinositide signaling in cells
by: Nile, A., et al.
Published: (2014)

PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma
by: Dituri, F., et al.
Published: (2012)

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
by: Serra, V., et al.
Published: (2011)

THE CLASS II PHOSPHOINOSITIDE 3-KINASE ISOFORM beta REGULATES PLATELET FUNCTION AND ARTERIAL THROMBOSIS IN MICE
by: Tibolla, G., et al.
Published: (2011)

Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
by: Singh, S., et al.
Published: (2015)

PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
by: Braccini, L., et al.
Published: (2015)

A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate
by: Falasca, Marco, et al.
Published: (2010)

PI3K-C2B PLAYS A KEY ROLE IN THE ACTIVATION AND THE PROLIFERATION OF T LYMPHOCYTES: IMPACT ON VASCULAR DISEASES
by: Balzarotti, G., et al.
Published: (2015)

PI3K CLASS 1B CONTROLS THE CELL CYCLE CHECKPOINT AT THE G2/M PHASE PROMOTING CELL PROLIFERATION IN HEPATOCELLULAR CARCINOMA
by: Dituri, F., et al.
Published: (2011)

Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2021)

Effects of high power electronics converters on PLC signals
by: Bashi, Senan Mahmod, et al.
Published: (2006)

A Potential Effect of Cordycepin on the Feedback between Polyadenylation and PI3K/Akt/mTOR Signalling
by: Lawrence, Steven
Published: (2023)

A simulation of PLC-based self-tuning PI-fuzzy logic controller for DC motor
by: N., Saad, et al.
Published: (2008)

Local control of phosphatidylinositol 4-phosphate signaling in the Golgi apparatus by Vps74 and Sac1 phosphoinositide phosphatase
by: Wood, C., et al.
Published: (2012)

Boyden chamber
by: Falasca, Marco, et al.
Published: (2011)

A PLC-based self-tuning PI-fuzzy controller for linear and non-linear drives control
by: N., Saad, et al.
Published: (2008)

Elucidation of the WNT & AKT/Phosphoinositide-3-Kinase Pathways in Colorectal Carcinoma
by: Khor, Tin Oo
Published: (2004)

Vitamin D and Stimulates the PI3K-AKT signaling pathway in insulin resistant SK-N-SH neuronal cells
by: Zaulkffali, Amirah Salwani, et al.
Published: (2019)

The effects of lauric acid on Pi3k and Nfκb signaling pathways in alcohol-induced hepg2 cells
by: Lua, Ying Huan
Published: (2018)

Lysophosphatidylinositol Signalling and Metabolic Diseases
by: Arifin, S., et al.
Published: (2016)

Investigating the role the PI3K pathway plays in ependymoma pathogenesis
by: Estranero, Jasper
Published: (2019)

Exploring the Effects of the Long Noncoding RNA MIR205HG on PI3K Inhibitor Resistance in Breast Cancer
by: Vasilevski, Natali
Published: (2025)